ALOXI Side Effects

7021637-X | Bilirubin Conjugated Increased, Blood Albumin Decreased, Blood Pressure Decreased, Blood Urea Increased, Cardiac Failure Congestive, Haemoglobin Decreased, White Blood Cell Count Increased
on Sep 15, 2010 Male patient from JAPAN , 73 years of age, weighting 147.7 lb, was diagnosed with prophylaxis of nausea and vomiting, metastatic gastric cancer and was treated with Aloxi (View Usage). Patient experienced the following unwanted or unexpected effects: bilirubin conjugated increased, blood albumin decreased, blood pressure decreased, blood urea increased, cardiac failure congestive, haemoglobin decreased, white blood cell count increased. Aloxi dosage: 0.75 Mg, Single, Intravenous. During the same period patient was treated with TS 1 (GIMERACIL, OTERACIL POTASSIUM, TEGAFUR) (50 Mg, Bid, Oral) (View Ts 1 (gimeracil, Oteracil Potassium, Tegafur) Review and Ts 1 (gimeracil, Oteracil Potassium, Tegafur) Label ), CISPLATIN (100 Mg, Iv Drip; 100 Mg, Qd, Iv Drip) (View Cisplatin Review and Cisplatin Label ), EMEND (120 Mg, Oral) (View Emend Review and Emend Label ), ANTIHYPERTENSIVES (View Antihypertensives Review and Antihypertensives Label ), PRIMPERAN ELIXIR (View Primperan Elixir Review and Primperan Elixir Label ), KYTRIL (View Kytril Review and Kytril Label ). Patient was hospitalized.

7018370-7 | Arteriospasm Coronary
Patient was taking Aloxi (View Usage). Patient had the following side effects: arteriospasm coronary on Sep 13, 2010 from UNITED STATES Additional patient health information: Male patient , 62 years of age, was diagnosed with prophylaxis of nausea and vomiting and. Aloxi dosage: 0.25mg Single Intravenous.

7015549-5 | Blood Pressure Decreased, Cardiac Failure Congestive, Respiratory Disorder
Adverse event was reported on Sep 10, 2010 by a Male patient taking Aloxi (View Usage) (Dosage: 0.75 Mg, Single, Intravenous) was diagnosed with prophylaxis of nausea and vomiting, metastatic gastric cancer and. Location: JAPAN , 73 years of age, After Aloxi was administered, patient had the following side effects: blood pressure decreased, cardiac failure congestive, respiratory disorder. During the same period patient was treated with TS 1 (GIMERACIL, OTERACIL POTASSIUM, TEGAFUR) (50 Mg, Bid, Oral) (View Ts 1 (gimeracil, Oteracil Potassium, Tegafur) Review and Ts 1 (gimeracil, Oteracil Potassium, Tegafur) Label ), CISPLATIN (100 Mg, Qd, Iv Drip) (View Cisplatin Review and Cisplatin Label ), EMEND (Oral) (View Emend Review and Emend Label ), ANTIHYPERTENSIVES (View Antihypertensives Review and Antihypertensives Label ). Patient was hospitalized.

7006378-7 | Lung Neoplasm Malignant, Malignant Neoplasm Progression, Metastases To Neck
on Aug 25, 2010 Male patient from UNITED STATES , 50 years of age, was diagnosed with prophylaxis of nausea and vomiting and was treated with Aloxi (View Usage). Patient experienced the following unwanted or unexpected effects: lung neoplasm malignant, malignant neoplasm progression, metastases to neck. Aloxi dosage: 0.25 Mg, Intravenous. During the same period patient was treated with CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), PACLITAXEL (View Paclitaxel Review and Paclitaxel Label ), GEMZAR (View Gemzar Review and Gemzar Label ), NEUPOGEN (View Neupogen Review and Neupogen Label ), ALIMTA (View Alimta Review and Alimta Label ), AVASTIN (SIMVASTATIN) (View Avastin (simvastatin) Review and Avastin (simvastatin) Label ), PROCRIT (View Procrit Review and Procrit Label ), ETHINYL LEUKINE (View Ethinyl Leukine Review and Ethinyl Leukine Label ).


7006375-1 | Blood Pressure Increased, Constipation, Diarrhoea, Diverticulitis, Dizziness, Haematocrit Decreased, Haemoglobin Decreased, Loss Of Consciousness, Rectal Haemorrhage
on Aug 31, 2010 Male patient from UNITED STATES , 74 years of age, weighting 147.9 lb, was diagnosed with prophylaxis of nausea and vomiting, prostate cancer (What is prostate cancer?) and was treated with Aloxi (View Usage). Patient had the following side effects: blood pressure increased, constipation (What is constipation?), diarrhoea, diverticulitis, dizziness (What is dizziness?), haematocrit decreased, haemoglobin decreased, loss of consciousness, rectal haemorrhage. Aloxi dosage: . During the same period patient was treated with DOCETAXEL (75 Mg/m2, Qd) (View Docetaxel Review and Docetaxel Label ), PREDNISOLONE ACETATE (5 Mg, Bid) (View Prednisolone Acetate Review and Prednisolone Acetate Label ), NORVASC (View Norvasc Review and Norvasc Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), COENZYME Q10 (View Coenzyme Q10 Review and Coenzyme Q10 Label ), CRESTOR (View Crestor Review and Crestor Label ), PLAVIX (View Plavix Review and Plavix Label ). Patient was hospitalized.

6973716-0 | Chest Discomfort, Dyspnoea, Hypotension
Patient was taking Aloxi (View Usage). After Aloxi was administered, patient had the following side effects: chest discomfort, dyspnoea, hypotension on Aug 26, 2010 from ITALY Additional patient health information: Female patient , 57 years of age, was diagnosed with prophylaxis of nausea and vomiting and. Aloxi dosage: 0.25 Mg, Single, Intravenous. During the same period patient was treated with DECADRON (DEXAMETHASONE SODIUM SUCCINATE) (View Decadron (dexamethasone Sodium Succinate) Review and Decadron (dexamethasone Sodium Succinate) Label ).

6959547-6 | Chest Discomfort, Dyspnoea, Hypotension
Adverse event was reported on Aug 19, 2010 by a Female patient taking Aloxi (View Usage) (Dosage: 0.25 Mg, Single, Intravenous) was diagnosed with prophylaxis of nausea and vomiting and. Location: ITALY , 57 years of age, Patient experienced the following unwanted or unexpected effects: chest discomfort, dyspnoea, hypotension. During the same period patient was treated with DECADRON (DEXAMETHASONE SODIUM SUCCINATE) (View Decadron (dexamethasone Sodium Succinate) Review and Decadron (dexamethasone Sodium Succinate) Label ).

6631383-X | Blister, Rash Pruritic
on Mar 11, 2010 Female patient from UNITED STATES , 67 years of age, weighting 131.0 lb, was diagnosed with nausea (What is nausea?) and was treated with Aloxi (View Usage). Patient had the following side effects: blister, rash pruritic. Aloxi dosage: 250 Micrograms Iv. During the same period patient was treated with IMODIUM (View Imodium Review and Imodium Label ), PHENERGAN HCL (View Phenergan Hcl Review and Phenergan Hcl Label ), TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ), ATIVAN (View Ativan Review and Ativan Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), ATROPINE (View Atropine Review and Atropine Label ), DECADRON (View Decadron Review and Decadron Label ).

6595173-9 | Lung Cancer Metastatic, Malignant Neoplasm Progression
on Jan 25, 2010 Female patient from UNITED STATES , 49 years of age, was diagnosed with prophylaxis of nausea and vomiting and was treated with Aloxi (View Usage). After Aloxi was administered, patient had the following side effects: lung cancer metastatic, malignant neoplasm progression. Aloxi dosage: 1 Or 2 Df, Intravenous.

6528549-6 | Abdominal Pain, Diarrhoea, Influenza, Vomiting
Patient was taking Aloxi (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), diarrhoea, influenza, vomiting on Dec 15, 2009 from SWEDEN Additional patient health information: Female patient , 39 years of age, weighting 169.8 lb, was diagnosed with prophylaxis of nausea and vomiting and. Aloxi dosage: 0.25mg, Single, Iv Bolus;0.25 Mg, Single, Iv Bolus;0.25mg, Single, Iv Bolus. During the same period patient was treated with BETAPRED BETAMETHASONE SODIUM PHOSPHATE) INJECTION (View Betapred Betamethasone Sodium Phosphate) Injection Review and Betapred Betamethasone Sodium Phosphate) Injection Label ), EMEND (View Emend Review and Emend Label ), ELOXATIN (View Eloxatin Review and Eloxatin Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), LEUKOVORIN (CALCIUM FOLINATE) (View Leukovorin (calcium Folinate) Review and Leukovorin (calcium Folinate) Label ), PRIMPERAN TAB (View Primperan Tab Review and Primperan Tab Label ).

6504758-7 | Gastroenteritis Viral
Adverse event was reported on Nov 30, 2009 by a Female patient taking Aloxi (View Usage) (Dosage: 0.25 Mg, Single, Iv Bolus) was diagnosed with prophylaxis of nausea and vomiting and. Location: SWEDEN , 39 years of age, weighting 169.8 lb, Patient had the following side effects: gastroenteritis viral. During the same period patient was treated with BETAPRED (BETAMETHASONE SODIUM PHOSPHATE) INJECTION (View Betapred (betamethasone Sodium Phosphate) Injection Review and Betapred (betamethasone Sodium Phosphate) Injection Label ), EMEND (ARPREPITANT) (View Emend (arprepitant) Review and Emend (arprepitant) Label ), ELOXATIN (View Eloxatin Review and Eloxatin Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), LEUKOVORIN (CALCIUM FOLINATE) (View Leukovorin (calcium Folinate) Review and Leukovorin (calcium Folinate) Label ), CORTISONE (CORTISONE) (View Cortisone (cortisone) Review and Cortisone (cortisone) Label ).

6410705-9 | Alanine Aminotransferase Increased, Anaphylactic Shock, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Lactate Dehydrogenase Increased, Gamma-glutamyltransferase Increased, Platelet Count Decreased
on Sep 30, 2009 Female patient from GERMANY , 65 years of age, weighting 178.6 lb, was diagnosed with prophylaxis of nausea and vomiting, colon cancer metastatic and was treated with Aloxi (View Usage). After Aloxi was administered, patient had the following side effects: alanine aminotransferase increased, anaphylactic shock, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, gamma-glutamyltransferase increased, platelet count decreased. Aloxi dosage: 0.25 Mg, Single, Intravenous. During the same period patient was treated with OXALIPLATIN (120 Mg, Single, Intravenous) (View Oxaliplatin Review and Oxaliplatin Label ), DEXAMETHASONE TAB (View Dexamethasone Tab Review and Dexamethasone Tab Label ), RESCUVOLIN (CALCIUM FOLINATE) (View Rescuvolin (calcium Folinate) Review and Rescuvolin (calcium Folinate) Label ).

6410694-7 | Hemiparesis, Hypoaesthesia, Hypotonia, Loss Of Consciousness, Procedural Complication, Syncope, Vision Blurred, Vitreous Floaters
on Sep 29, 2009 Female patient from UNITED STATES , 62 years of age, weighting 153.9 lb, was diagnosed with prophylaxis of nausea and vomiting and was treated with Aloxi (View Usage). Patient experienced the following unwanted or unexpected effects: hemiparesis, hypoaesthesia, hypotonia, loss of consciousness, procedural complication, syncope, vision blurred, vitreous floaters. Aloxi dosage: 0.25 Mg, Single, Iv Bolus. Patient was hospitalized.

6382405-5 | Feeling Abnormal, Hypersensitivity, Hypoaesthesia Oral, Paraesthesia Oral, Speech Disorder, Swollen Tongue
Patient was taking Aloxi (View Usage). Patient had the following side effects: feeling abnormal, hypersensitivity, hypoaesthesia oral, paraesthesia oral, speech disorder, swollen tongue on Aug 26, 2008 from UNITED STATES Additional patient health information: Female patient , 55 years of age, was diagnosed with prophylaxis of nausea and vomiting and. Aloxi dosage: 0.25 Mg, Single, Iv Bolus. During the same period patient was treated with DECADRON (View Decadron Review and Decadron Label ), PEPCID (View Pepcid Review and Pepcid Label ), BENADRYL (View Benadryl Review and Benadryl Label ), OXALIPLATIN (View Oxaliplatin Review and Oxaliplatin Label ), 5 FU /000968801/(FLUOROURACIL) (View 5-fu /000968801/(fluorouracil) Review and 5-fu /000968801/(fluorouracil) Label ), LEUCOVORIN /00566701/(FOLINIC ACID) (View Leucovorin /00566701/(folinic Acid) Review and Leucovorin /00566701/(folinic Acid) Label ).

6367495-8 | Bradycardia
Adverse event was reported on Aug 25, 2009 by a Female patient taking Aloxi (View Usage) (Dosage: 0.25 Mg, Single, Intravenous; 0.25 Mg, Single, Intravenous) . Location: UNITED STATES , 42 years of age, After Aloxi was administered, patient had the following side effects: bradycardia.

6348846-7 | Hypotonia, Myodesopsia, Syncope
on Aug 20, 2009 Female patient from UNITED STATES , 62 years of age, was diagnosed with prophylaxis of nausea and vomiting and was treated with Aloxi (View Usage). Patient experienced the following unwanted or unexpected effects: hypotonia, myodesopsia, syncope. Aloxi dosage: 0.25 Mg, Single, Iv Bolus. Patient was hospitalized.

6331823-X | Blepharospasm, Muscle Spasms, Sensation Of Heaviness
on Aug 12, 2009 Female patient from UNITED STATES , 43 years of age, was diagnosed with prophylaxis of nausea and vomiting and was treated with Aloxi (View Usage). Patient had the following side effects: blepharospasm, muscle spasms, sensation of heaviness. Aloxi dosage: 0.25 Mg, Single, Intravenous, 0.25 Mg, Single, Intravenous. Patient was hospitalized.

6192999-0 | Abdominal Pain, Asthenia, Blood Urea Increased, Cerebrovascular Accident, Constipation, Dehydration, Hypophagia, Malnutrition, Oedema Peripheral
Patient was taking Aloxi (View Usage). After Aloxi was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), asthenia, blood urea increased, cerebrovascular accident, constipation (What is constipation?), dehydration, hypophagia, malnutrition, oedema peripheral on Apr 29, 2009 from UNITED STATES Additional patient health information: Male patient , 68 years of age, was diagnosed with prophylaxis of nausea and vomiting, oedema peripheral, colorectal cancer metastatic and. Aloxi dosage: 0.25 Mg, Single, Intravenous. During the same period patient was treated with LASIX (Oral) (View Lasix Review and Lasix Label ), ALDACTONE (Oral) (View Aldactone Review and Aldactone Label ), LEUCOVORIN CALCIUM (View Leucovorin Calcium Review and Leucovorin Calcium Label ), OXALIPLATIN (150 Mg, Intravenous) (View Oxaliplatin Review and Oxaliplatin Label ), AG 013 736(AG 013 736) (AXIT (5 Mg, Q12h, Oral) (View Ag-013 736(ag-013 736) (axit Review and Ag-013 736(ag-013 736) (axit Label ), FLUOROURACIL (720 Mg, Qd, Iv Bolus; 4300 Mg, Single, Iv Drip) (View Fluorouracil Review and Fluorouracil Label ). Patient was hospitalized.

6182990-2 | Dyspnoea, White Blood Cell Count Increased
Adverse event was reported on Apr 20, 2009 by a Female patient taking Aloxi (View Usage) (Dosage: 250 Ug, Intravenous) was diagnosed with prophylaxis of nausea and vomiting, lung neoplasm malignant and. Location: ITALY , 69 years of age, Patient experienced the following unwanted or unexpected effects: dyspnoea, white blood cell count increased. During the same period patient was treated with GEMZAR (1570 Mg, Intravenous) (View Gemzar Review and Gemzar Label ), CISPLATIN (110 Mg, Intravenous) (View Cisplatin Review and Cisplatin Label ), MANNITOL (MANNITOL) SOLUTION (EXCEPT SYRUP) (View Mannitol (mannitol) Solution (except Syrup) Review and Mannitol (mannitol) Solution (except Syrup) Label ). Patient was hospitalized.

6153035-5 | Cardio-respiratory Arrest, Epilepsy, Vertigo
on Mar 26, 2009 Female patient from SWITZERLAND , 73 years of age, was diagnosed with prophylaxis of nausea and vomiting and was treated with Aloxi (View Usage). Patient had the following side effects: cardio-respiratory arrest, epilepsy (What is epilepsy?), vertigo. Aloxi dosage: 0.25 Mg, Single, Iv Drip. During the same period patient was treated with CODEINE SUL TAB (View Codeine Sul Tab Review and Codeine Sul Tab Label ), COSAAR PLUS (HYDROCHLOROTHIAZIDE, LOSARTAN POTASSIUM) (View Cosaar Plus (hydrochlorothiazide, Losartan Potassium) Review and Cosaar Plus (hydrochlorothiazide, Losartan Potassium) Label ).

6073413-2 | Grand Mal Convulsion, Heart Rate Increased
on Feb 05, 2009 Female patient from ITALY , 42 years of age, was diagnosed with prophylaxis of nausea and vomiting and was treated with Aloxi (View Usage). After Aloxi was administered, patient had the following side effects: grand mal convulsion, heart rate increased. Aloxi dosage: 0.25 Mg, Single, Iv Bolus. During the same period patient was treated with 5 FU /00098801/ (FLUOROURACIL) (View 5-fu /00098801/ (fluorouracil) Review and 5-fu /00098801/ (fluorouracil) Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), EPIRUBICIN (View Epirubicin Review and Epirubicin Label ), DEXAMETHASONE TAB (View Dexamethasone Tab Review and Dexamethasone Tab Label ). Patient was hospitalized.

6073188-7 | Anaphylactic Shock, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Glucose Increased, Cyanosis, Gamma-glutamyltransferase Increased, Haematocrit Increased, Haemoglobin Increased, Hypersensitivity
Patient was taking Aloxi (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic shock, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood glucose increased, cyanosis, gamma-glutamyltransferase increased, haematocrit increased, haemoglobin increased, hypersensitivity on Jan 21, 2009 from GERMANY Additional patient health information: Female patient , 59 years of age, weighting 163.1 lb, was diagnosed with prophylaxis of nausea and vomiting and. Aloxi dosage: 0.25mg, Single, Intravenous. During the same period patient was treated with DEXAMETHASON (DEDAMETHASONE) (View Dexamethason (dedamethasone) Review and Dexamethason (dedamethasone) Label ), TAVEGYL (CLEMASTINE) (View Tavegyl (clemastine) Review and Tavegyl (clemastine) Label ). Patient was hospitalized.

6073185-1 | Alanine Aminotransferase Increased, Anaphylactic Shock, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Lactate Dehydrogenase Increased, Carcinoembryonic Antigen Increased, Gamma-glutamyltransferase Increased, Mean Cell Haemoglobin Increased, Mean Cell Volume Abnormal
Adverse event was reported on Jan 21, 2009 by a Female patient taking Aloxi (View Usage) (Dosage: 0.25mg, Single, Intravenous) was diagnosed with prophylaxis of nausea and vomiting, colon cancer metastatic and. Location: GERMANY , 65 years of age, weighting 178.6 lb, Patient had the following side effects: alanine aminotransferase increased, anaphylactic shock, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, carcinoembryonic antigen increased, gamma-glutamyltransferase increased, mean cell haemoglobin increased, mean cell volume abnormal. During the same period patient was treated with OXALIPLATIN (View Oxaliplatin Review and Oxaliplatin Label ).

6028000-9 | Epilepsy, Hypersensitivity, Hypoxia, Stress, Syncope
on Dec 17, 2008 Female patient from SWITZERLAND , 61 years of age, was diagnosed with prophylaxis of nausea and vomiting and was treated with Aloxi (View Usage). After Aloxi was administered, patient had the following side effects: epilepsy (What is epilepsy?), hypersensitivity, hypoxia, stress (What is stress?), syncope. Aloxi dosage: 0.25 Mg, Single, Iv Drip. During the same period patient was treated with 5 FU/00098801/(FLUOROURACIL) (View 5-fu/00098801/(fluorouracil) Review and 5-fu/00098801/(fluorouracil) Label ), EPIRUBICIN (View Epirubicin Review and Epirubicin Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), TAXOTERE (View Taxotere Review and Taxotere Label ). Patient was hospitalized.

6016917-0 | Anaphylactic Shock, Respiratory Arrest
on Dec 03, 2008 Female patient from GERMANY , 60 years of age, was treated with Aloxi (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic shock, respiratory arrest. Aloxi dosage: .

5961135-5 | Gastric Cancer
Patient was taking Aloxi (View Usage). Patient had the following side effects: gastric cancer on Nov 03, 2008 from UNITED STATES Additional patient health information: Male patient , 59 years of age, was diagnosed with prophylaxis of nausea and vomiting, gastric cancer and. Aloxi dosage: 0.25 Mg, Intravenous. During the same period patient was treated with GLEEVEC (View Gleevec Review and Gleevec Label ).

5957541-5 | Electrocardiogram Qt Prolonged, Electrocardiogram T Wave Inversion, Fall, Lower Limb Fracture, Lymphoma, Syncope
Adverse event was reported on Oct 30, 2008 by a Female patient taking Aloxi (View Usage) (Dosage: 0.25 Mg, Single, Intravenous) was diagnosed with prophylaxis of nausea and vomiting and. Location: NORWAY , 42 years of age, After Aloxi was administered, patient had the following side effects: electrocardiogram qt prolonged, electrocardiogram t wave inversion, fall (What is fall?), lower limb fracture, lymphoma (What is lymphoma?), syncope. During the same period patient was treated with NYSARTIN(NYSARTIN) (View Nysartin(nysartin) Review and Nysartin(nysartin) Label ), APREPITANT (APREPITANT) (View Aprepitant (aprepitant) Review and Aprepitant (aprepitant) Label ), CARMUSTINE (View Carmustine Review and Carmustine Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ), MELPHALAN(MELPHALAN) (View Melphalan(melphalan) Review and Melphalan(melphalan) Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ).

5928891-3 | Flushing, Hypersensitivity, Nausea, Tongue Oedema
on Mar 20, 2008 Female patient from UNITED STATES , 66 years of age, weighting 143.1 lb, was diagnosed with prophylaxis of nausea and vomiting, colon cancer and was treated with Aloxi (View Usage). Patient experienced the following unwanted or unexpected effects: flushing, hypersensitivity, nausea (What is nausea?), tongue oedema. Aloxi dosage: 0.25 Mg, Single, Intravenous. During the same period patient was treated with ELOXATIN (130 Mg, Single, Intravenous) (View Eloxatin Review and Eloxatin Label ), DECADRON (View Decadron Review and Decadron Label ), 5 FU /000098801/ (FLUOROOURACIL) (View 5-fu /000098801/ (fluoroouracil) Review and 5-fu /000098801/ (fluoroouracil) Label ), LEUCOVORIN /00566701/ (FOLINIC ACID) (View Leucovorin /00566701/ (folinic Acid) Review and Leucovorin /00566701/ (folinic Acid) Label ), COREG (View Coreg Review and Coreg Label ), ZOCOR (View Zocor Review and Zocor Label ), PRINIVIL (View Prinivil Review and Prinivil Label ), LASIX (View Lasix Review and Lasix Label ).

5893748-3 | Convulsion, Tremor
on Sep 08, 2008 Female patient from ITALY , 42 years of age, was diagnosed with prophylaxis of nausea and vomiting and was treated with Aloxi (View Usage). Patient had the following side effects: convulsion, tremor. Aloxi dosage: 0.25 Mg, Single, Intravenous. During the same period patient was treated with 5 FU /00098801/ (FLUOROURACIL) (View 5-fu /00098801/ (fluorouracil) Review and 5-fu /00098801/ (fluorouracil) Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), EPIRUBICIN (View Epirubicin Review and Epirubicin Label ), DEXAMETHASONE TAB (View Dexamethasone Tab Review and Dexamethasone Tab Label ). Patient was hospitalized.

5892246-0 | Blood Glucose Increased, Bradycardia, Hyperhidrosis, Hypotension
Patient was taking Aloxi (View Usage). After Aloxi was administered, patient had the following side effects: blood glucose increased, bradycardia, hyperhidrosis, hypotension on Sep 05, 2008 from UNITED STATES Additional patient health information: Female patient , 88 years of age, weighting 121.0 lb, . Aloxi dosage: 0.25 Mg, Single, Intravenous. During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ), ZOCOR (View Zocor Review and Zocor Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), LASIX (View Lasix Review and Lasix Label ), AMARYL (View Amaryl Review and Amaryl Label ), COREG (View Coreg Review and Coreg Label ), COSOPT /01553801/ (DORZOLAMIDE, TIMOLOL) (View Cosopt /01553801/ (dorzolamide, Timolol) Review and Cosopt /01553801/ (dorzolamide, Timolol) Label ), TRAVATAN (View Travatan Review and Travatan Label ).

5892244-7 | Dizziness, Dysarthria, Hypoaesthesia, Lethargy, Posture Abnormal, Speech Disorder
Adverse event was reported on Sep 05, 2008 by a Male patient taking Aloxi (View Usage) (Dosage: 0.25mg, Single, Intravenous) was diagnosed with prophylaxis of nausea and vomiting and. Location: UNITED STATES , 84 years of age, weighting 153.9 lb, Patient experienced the following unwanted or unexpected effects: dizziness (What is dizziness?), dysarthria, hypoaesthesia, lethargy, posture abnormal, speech disorder. During the same period patient was treated with DECARDRON /00016001/ (DEXAMETHASONE) (View Decardron /00016001/ (dexamethasone) Review and Decardron /00016001/ (dexamethasone) Label ), FLOMAX /00889901/ (MORNIFLUMATE) (View Flomax /00889901/ (morniflumate) Review and Flomax /00889901/ (morniflumate) Label ), AVODART (View Avodart Review and Avodart Label ), VIAGRA /0136750/ (SILDENAFIL) (View Viagra /0136750/ (sildenafil) Review and Viagra /0136750/ (sildenafil) Label ), PENALAC (CICLOPIROX) SOLUTION (EXCEPT SYRUP) (View Penalac (ciclopirox) Solution (except Syrup) Review and Penalac (ciclopirox) Solution (except Syrup) Label ), PEPCID /00706001/ (FAMOTIDINE) (View Pepcid /00706001/ (famotidine) Review and Pepcid /00706001/ (famotidine) Label ).

5818357-3 | Convulsion, Syncope
on Jul 02, 2008 Female patient from SWITZERLAND , 61 years of age, was diagnosed with prophylaxis of nausea and vomiting and was treated with Aloxi (View Usage). Patient had the following side effects: convulsion, syncope. Aloxi dosage: 0.25 Mg, Single, Iv Drip.

5728476-8 | Iatrogenic Injury, Stevens-johnson Syndrome
on Apr 17, 2008 Male patient from ITALY , 66 years of age, was diagnosed with prophylaxis of nausea and vomiting and was treated with Aloxi (View Usage). After Aloxi was administered, patient had the following side effects: iatrogenic injury, stevens-johnson syndrome. Aloxi dosage: 0.25 Mg, Single, Intravenous. During the same period patient was treated with CISPLATIN (100 Mg, Single, Intravenous) (View Cisplatin Review and Cisplatin Label ), GEMZAR (1600 Mg, Single, Intravenous) (View Gemzar Review and Gemzar Label ), OXYCONTIN (OXYCODOEN HYDROCHLORIDE) (View Oxycontin (oxycodoen Hydrochloride) Review and Oxycontin (oxycodoen Hydrochloride) Label ).

5712672-X | Anaphylactoid Reaction, Bronchospasm, Loss Of Consciousness
Patient was taking Aloxi (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactoid reaction, bronchospasm, loss of consciousness on Apr 04, 2008 from SWITZERLAND Additional patient health information: Male patient , 52 years of age, was diagnosed with prophylaxis of nausea and vomiting, lung neoplasm malignant and. Aloxi dosage: 0.25 Mg, Single, Intravenous. During the same period patient was treated with TAXOL (View Taxol Review and Taxol Label ), DEXAMETHASONE TAB (View Dexamethasone Tab Review and Dexamethasone Tab Label ), TAVEGYL /00137201/ (CLEMASTINE) (View Tavegyl /00137201/ (clemastine) Review and Tavegyl /00137201/ (clemastine) Label ), RANITIDINE HCL (View Ranitidine Hcl Review and Ranitidine Hcl Label ).

5656661-2 | Anxiety, Dizziness, Headache, Hypoaesthesia
Adverse event was reported on Mar 06, 2008 by a Male patient taking Aloxi (View Usage) (Dosage: 0.25mg X1 Iv Bolus) . Location: UNITED STATES , 55 years of age, weighting 180.0 lb, Patient had the following side effects: anxiety (What is anxiety?), dizziness (What is dizziness?), headache (What is headache?), hypoaesthesia. During the same period patient was treated with EMEND (115mg X1 Iv Drip) (View Emend Review and Emend Label ), DEXAMETHASONE TAB (View Dexamethasone Tab Review and Dexamethasone Tab Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), DIPHENHYDRAMINE HCL (View Diphenhydramine Hcl Review and Diphenhydramine Hcl Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ).

5633770-5 | Deep Vein Thrombosis
on Feb 13, 2008 Female patient from SWITZERLAND , 48 years of age, was diagnosed with prophylaxis of nausea and vomiting, breast cancer (What is breast cancer?) and was treated with Aloxi (View Usage). After Aloxi was administered, patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?). Aloxi dosage: 0.25 Mg, Single, Intravenous. During the same period patient was treated with EPIRUBICIN (Intravenous) (View Epirubicin Review and Epirubicin Label ), CYTOXAN (Intravenous) (View Cytoxan Review and Cytoxan Label ), MEPHAMESON /00016001 /(DEXAMETHASONE) (Intravenous) (View Mephameson /00016001 /(dexamethasone) Review and Mephameson /00016001 /(dexamethasone) Label ).

5517397-1 | Anaphylactoid Reaction, Bronchospasm, Loss Of Consciousness
on Oct 29, 2007 Male patient from SWITZERLAND , 52 years of age, was diagnosed with prophylaxis of nausea and vomiting and was treated with Aloxi (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactoid reaction, bronchospasm, loss of consciousness. Aloxi dosage: 0.25 Mg, Single, Intravenous. During the same period patient was treated with TAXOL (View Taxol Review and Taxol Label ), DEXAMETHASONE TAB (View Dexamethasone Tab Review and Dexamethasone Tab Label ), TAVEGYL /00137201/ (CLEMASTINE) (View Tavegyl /00137201/ (clemastine) Review and Tavegyl /00137201/ (clemastine) Label ), RANITIDINE HCL (View Ranitidine Hcl Review and Ranitidine Hcl Label ).

5517395-8 | Anaphylactoid Reaction, Stupor
Patient was taking Aloxi (View Usage). Patient had the following side effects: anaphylactoid reaction, stupor on Oct 29, 2007 from SWITZERLAND Additional patient health information: Male patient , 70 years of age, was diagnosed with prophylaxis of nausea and vomiting and. Aloxi dosage: 0.25 Mg, Single, Intravenous. During the same period patient was treated with ETOPOSIDE (180 Mg, Intravenous) (View Etoposide Review and Etoposide Label ), CARBOPLATIN (525 Mg, Intravenous) (View Carboplatin Review and Carboplatin Label ).

5474172-4 | Ascites, Blood Albumin Decreased, Blood Glucose Increased, Blood Pressure Increased, Cardiac Arrest, Clostridial Infection, Deep Vein Thrombosis, Diarrhoea, Dizziness
Adverse event was reported on Sep 14, 2007 by a Female patient taking Aloxi (View Usage) (Dosage: 0.25 Mg,qwk, Iv Bolus; 0.25 Mg, Qwk, Iv Bolus) was diagnosed with prophylaxis of nausea and vomiting and. Location: UNITED STATES , 60 years of age, weighting 257.9 lb, After Aloxi was administered, patient had the following side effects: ascites, blood albumin decreased, blood glucose increased, blood pressure increased, cardiac arrest (What is cardiac arrest?), clostridial infection, deep vein thrombosis (What is deep vein thrombosis?), diarrhoea, dizziness (What is dizziness?). During the same period patient was treated with TAGAMET (300 Mg, Single, Intravenous; 300 Mg, Single, Intravenous) (View Tagamet Review and Tagamet Label ), DECADRON (20 Mg, Qwk, Intrvaneous; 10 Qwk, Intravenous; 20 Mg, Qwk, Intravenous) (View Decadron Review and Decadron Label ), CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), TAXOL (View Taxol Review and Taxol Label ). Patient was hospitalized.

5448589-8 | Ascites, Blood Albumin Decreased, Blood Glucose Increased, Blood Pressure Immeasurable, Blood Pressure Increased, Cardiac Arrest, Clostridium Difficile Colitis, Conduction Disorder, Deep Vein Thrombosis
on Aug 20, 2007 Female patient from UNITED STATES , 60 years of age, weighting 257.9 lb, was diagnosed with prophylaxis of nausea and vomiting and was treated with Aloxi (View Usage). Patient experienced the following unwanted or unexpected effects: ascites, blood albumin decreased, blood glucose increased, blood pressure immeasurable, blood pressure increased, cardiac arrest (What is cardiac arrest?), clostridium difficile colitis, conduction disorder, deep vein thrombosis (What is deep vein thrombosis?). Aloxi dosage: 0.25 Mg, Qwk, Iv Bolus; 0.25 Mg, Qwk, Iv Bolus. During the same period patient was treated with TAGAMET (300 Mg, Single, Intravenous; 300 Mg, Single, Intravenous) (View Tagamet Review and Tagamet Label ), DECADRON (20 Mg, Qwk, Intravenous; 10 Mg, Qwk, Intravenous; 20 Mg, Qwk, Intravenous) (View Decadron Review and Decadron Label ), CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), TAXOL (View Taxol Review and Taxol Label ). Patient was hospitalized.

5448588-6 | Blood Pressure Systolic Increased, Dizziness, Heart Rate Increased, Oxygen Saturation Decreased, Pulse Pressure Decreased, Rash Erythematous, Syncope Vasovagal, Unresponsive To Stimuli, Vision Blurred
on Aug 20, 2007 Female patient from UNITED STATES , 70 years of age, weighting 148.8 lb, was diagnosed with prophylaxis of nausea and vomiting and was treated with Aloxi (View Usage). Patient had the following side effects: blood pressure systolic increased, dizziness (What is dizziness?), heart rate increased, oxygen saturation decreased, pulse pressure decreased, rash erythematous, syncope vasovagal, unresponsive to stimuli, vision blurred. Aloxi dosage: 0.25 Mg, Qwk, Iv Bolus; 0.25 Mg, Qwk, Iv Bolus. During the same period patient was treated with DECADRON (10 Mg, Qwk, Intravenous; 20 Mg, Qwk, Intravenous; 10 Mg, Qwk, Intravenous) (View Decadron Review and Decadron Label ), TAXOL (View Taxol Review and Taxol Label ), CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), ARANESP (View Aranesp Review and Aranesp Label ), TAGAMET /00397401/ (CIMETIDINE) (View Tagamet /00397401/ (cimetidine) Review and Tagamet /00397401/ (cimetidine) Label ).

5246789-3 | Back Pain, Bone Pain, Headache, Heart Rate Increased, Infusion Related Reaction, Neck Pain
Patient was taking Aloxi (View Usage). After Aloxi was administered, patient had the following side effects: back pain (What is back pain?), bone pain, headache (What is headache?), heart rate increased, infusion related reaction, neck pain on Feb 23, 2007 from UNITED STATES Additional patient health information: Female patient , weighting 145.3 lb, . Aloxi dosage: .

5246788-1 | Blood Pressure Systolic Increased, Depressed Level Of Consciousness, Erythema, Flushing, Infusion Related Reaction, Pharyngeal Oedema
Adverse event was reported on Feb 23, 2007 by a Female patient taking Aloxi (View Usage) (Dosage: ) . Location: UNITED STATES , weighting 176.0 lb, Patient experienced the following unwanted or unexpected effects: blood pressure systolic increased, depressed level of consciousness, erythema, flushing, infusion related reaction, pharyngeal oedema. During the same period patient was treated with OXALIPLATIN (View Oxaliplatin Review and Oxaliplatin Label ).

5173633-5 | Abdominal Pain Upper, Chest Pain, Condition Aggravated, Constipation, Intestinal Obstruction
on Nov 21, 2006 Female patient from UNITED STATES , 52 years of age, weighting 132.3 lb, was diagnosed with prophylaxis of nausea and vomiting and was treated with Aloxi (View Usage). Patient had the following side effects: abdominal pain upper, chest pain (What is chest pain?), condition aggravated, constipation (What is constipation?), intestinal obstruction. Aloxi dosage: See Image. During the same period patient was treated with DECADRON (View Decadron Review and Decadron Label ), CISPLATIN (View Cisplatin Review and Cisplatin Label ), GEMZAR (View Gemzar Review and Gemzar Label ), COLACE (DOCUSATE SODIUM) (View Colace (docusate Sodium) Review and Colace (docusate Sodium) Label ), MIRALAX (View Miralax Review and Miralax Label ), LACTULOSE (View Lactulose Review and Lactulose Label ), DULCOLAX (View Dulcolax Review and Dulcolax Label ).

5152502-0 | Hypoacusis, Ototoxicity
on Oct 25, 2006 Male patient from ITALY , 69 years of age, was diagnosed with prophylaxis of nausea and vomiting, lung adenocarcinoma metastatic, diuretic effect and was treated with Aloxi (View Usage). After Aloxi was administered, patient had the following side effects: hypoacusis, ototoxicity. Aloxi dosage: 0.25 Mg, Single, Intravenous. During the same period patient was treated with CISPLATIN (140 Mg, Single, Intravenous) (View Cisplatin Review and Cisplatin Label ), NAVELBINE (45 Mg, Single, Intravenous; See Image) (View Navelbine Review and Navelbine Label ), FUROSEMIDE (20 Mg, Single, Intravenous) (View Furosemide Review and Furosemide Label ), SOLDESAM (DEXAMETHASONE SODIUM PHOSPHATE) (View Soldesam (dexamethasone Sodium Phosphate) Review and Soldesam (dexamethasone Sodium Phosphate) Label ), ZOFRAN /00955301/ (ONDANSETRON) (View Zofran /00955301/ (ondansetron) Review and Zofran /00955301/ (ondansetron) Label ).

5152501-9 | Abortion Missed
Patient was taking Aloxi (View Usage). Patient experienced the following unwanted or unexpected effects: abortion missed on Oct 25, 2006 from IRELAND Additional patient health information: Female patient , 38 years of age, was diagnosed with prophylaxis of nausea and vomiting and. Aloxi dosage: Intravenous. During the same period patient was treated with MABTHERA (RITUXIMAB) (Intravenous) (View Mabthera (rituximab) Review and Mabthera (rituximab) Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), VINCRISTINE SULFATE (View Vincristine Sulfate Review and Vincristine Sulfate Label ), DOXORUBICIN HCL (Infusion) (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), RITUXIMAB (RITUXIM (View Rituximab (rituxim Review and Rituximab (rituxim Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ).

5126881-4 | Chest Discomfort, Dyspnoea, Hypersensitivity
Adverse event was reported on Jul 20, 2006 by a Female patient taking Aloxi (View Usage) (Dosage: See Image) was diagnosed with prophylaxis of nausea and vomiting, peritoneal carcinoma and. Location: UNITED STATES , 40 years of age, weighting 254.0 lb, Patient had the following side effects: chest discomfort, dyspnoea, hypersensitivity. During the same period patient was treated with DOXORUBICIN HCL (80 Mg, Single, Intravenous) (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), BENADRYL /00000402/(DIPHENHYDRAMINE HYDROCHLORIDE) (View Benadryl /00000402/(diphenhydramine Hydrochloride) Review and Benadryl /00000402/(diphenhydramine Hydrochloride) Label ), CIMETIDINE (View Cimetidine Review and Cimetidine Label ), SENOKOT /00142201/(SENNA ALEXANDRINA) (View Senokot /00142201/(senna Alexandrina) Review and Senokot /00142201/(senna Alexandrina) Label ), LEXAPRO (View Lexapro Review and Lexapro Label ).

5126876-0 | Injection Site Irritation
on Jul 10, 2006 Female patient from UNITED STATES , 56 years of age, weighting 159.0 lb, was diagnosed with prophylaxis of nausea and vomiting and was treated with Aloxi (View Usage). After Aloxi was administered, patient had the following side effects: injection site irritation. Aloxi dosage: See Image. During the same period patient was treated with EFFEXOR XR (View Effexor Xr Review and Effexor Xr Label ), DEPAKOTE (View Depakote Review and Depakote Label ), TRILAFON /00023401/(PERPHENAZINE) (View Trilafon /00023401/(perphenazine) Review and Trilafon /00023401/(perphenazine) Label ), AMBIEN (View Ambien Review and Ambien Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), LEVOXYL (View Levoxyl Review and Levoxyl Label ), MULTIVITAMIN /00831701/(VITAMINS NOS) (View Multivitamin /00831701/(vitamins Nos) Review and Multivitamin /00831701/(vitamins Nos) Label ).

5126868-1 | Nausea
on Jun 06, 2006 Female patient from UNITED STATES , 48 years of age, weighting 138.9 lb, was diagnosed with prophylaxis of nausea and vomiting and was treated with Aloxi (View Usage). Patient experienced the following unwanted or unexpected effects: nausea (What is nausea?). Aloxi dosage: 0.25 Mg, Single, Iv Bolus. During the same period patient was treated with DECADRON /00016001/(DEXAMETHASONE) (View Decadron /00016001/(dexamethasone) Review and Decadron /00016001/(dexamethasone) Label ), OXALIPLATIN (View Oxaliplatin Review and Oxaliplatin Label ), CALCIUM GLUCONATE (View Calcium Gluconate Review and Calcium Gluconate Label ), MAGNESIUM SULFATE (View Magnesium Sulfate Review and Magnesium Sulfate Label ), LIPITOR /01326101/ (ATORVASTATIN) (View Lipitor /01326101/ (atorvastatin) Review and Lipitor /01326101/ (atorvastatin) Label ), NEXIUM (View Nexium Review and Nexium Label ), FOSAMAX (View Fosamax Review and Fosamax Label ).

5126864-4 | Vomiting
Patient was taking Aloxi (View Usage). Patient had the following side effects: vomiting on May 19, 2006 from UNITED STATES Additional patient health information: Male patient , 44 years of age, weighting 194.0 lb, was diagnosed with prophylaxis of nausea and vomiting and. Aloxi dosage: 0.25 Mg, Single, Intravenous. During the same period patient was treated with DEXAMETHASONE TAB (20 Mg, Single, Oral) (View Dexamethasone Tab Review and Dexamethasone Tab Label ), DTIC DOME (View Dtic-dome Review and Dtic-dome Label ), ADRIAMYCIN /00330901/ (DOXORUBICIN) (View Adriamycin /00330901/ (doxorubicin) Review and Adriamycin /00330901/ (doxorubicin) Label ), BLEOMYCIN (View Bleomycin Review and Bleomycin Label ), VELBAN (View Velban Review and Velban Label ).